BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, announced the submission of a Fentanyl Lauriad clinical trial application to the French Drug Agency (AFSSaPS) and its approval by the Ethics Committee (Comité de Protection des Personnes).
[News Source]
[News Source]
Blogosphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg


